Luc G.T. Morris

35.8k total citations · 6 hit papers
221 papers, 12.1k citations indexed

About

Luc G.T. Morris is a scholar working on Surgery, Oncology and Otorhinolaryngology. According to data from OpenAlex, Luc G.T. Morris has authored 221 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Surgery, 93 papers in Oncology and 60 papers in Otorhinolaryngology. Recurrent topics in Luc G.T. Morris's work include Head and Neck Cancer Studies (54 papers), Thyroid Cancer Diagnosis and Treatment (40 papers) and Cancer Immunotherapy and Biomarkers (35 papers). Luc G.T. Morris is often cited by papers focused on Head and Neck Cancer Studies (54 papers), Thyroid Cancer Diagnosis and Treatment (40 papers) and Cancer Immunotherapy and Biomarkers (35 papers). Luc G.T. Morris collaborates with scholars based in United States, Germany and Netherlands. Luc G.T. Morris's co-authors include Ian Ganly, Timothy A. Chan, Andrew G. Sikora, Louise Davies, Nadeem Riaz, Snehal G. Patel, Jatin P. Shah, Ashok R. Shaha, Timothy A. Chan and Richard J. Wong and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Luc G.T. Morris

213 papers receiving 11.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

2012 1.4k citations Logan A. Walsh, Luc G.T. Morris et al. profile →
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

2017 738 citations Diego Chowell, Luc G.T. Morris et al. Science profile →
The head and neck cancer immune landscape and its immunotherapeutic implications

2016 551 citations Alexis Desrichard, Martin G. Dalin et al. JCI Insight profile →
The Increasing Incidence of Thyroid Cancer: The Influence of Access to Care

2013 397 citations Luc G.T. Morris, Andrew G. Sikora et al. profile →
Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic

2020 394 citations Babak Givi, Luc G.T. Morris et al. profile →
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features

2024 50 citations Cristina Valero, Seong‐Keun Yoo et al. profile →

Peers

Countries citing papers authored by Luc G.T. Morris

Since Specialization

Citations

This map shows the geographic impact of Luc G.T. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc G.T. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc G.T. Morris more than expected).

Fields of papers citing papers by Luc G.T. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc G.T. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc G.T. Morris. The network helps show where Luc G.T. Morris may publish in the future.

Co-authorship network of co-authors of Luc G.T. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Luc G.T. Morris. A scholar is included among the top collaborators of Luc G.T. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc G.T. Morris. Luc G.T. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer 2025 ·Journal of Clinical Oncology ·Barbara Burtness, Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, (unknown), Seungwon Kim, Bert W. O’Malley, Enver Özer, Chukwuemeka Ikpeazu, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Mihir R. Patel, Miriam N. Lango, Luc G.T. Morris, Russell K. Smith, Daniel W. Karakla, Jeremy D. Richmon, F. Christopher Holsinger, Robert L. Ferris	4
2	Sympathetic axonogenesis promotes adenoid cystic carcinoma progression 2025 ·The Journal of Experimental Medicine ·(unknown), (unknown), Nora Katabi, (unknown), (unknown), Alan L. Ho, Luc G.T. Morris, Richard L. Bakst, Anuraag S. Parikh, Yotam Drier, Sylvie Deborde, Richard J. Wong	3
3	Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma 2024 ·JCI Insight ·Joris L. Vos, Joleen J.H. Traets, Xiaohang Qiao, Iris M. Seignette, Dennis Peters, Michel W.J.M. Wouters, Erik Hooijberg, Annegien Broeks, Jacqueline E. van der Wal, Barış Karakullukçu, W. Martin C. Klop, Arash Navran, Marc van Beurden, Oscar R. Brouwer, Luc G.T. Morris, Mariëtte I.E. van Poelgeest, Ellen Kapiteijn, John B.A.G. Haanen, Christian U. Blank, Charlotte L. Zuur	5
4	Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort 2024 ·Molecular Diagnosis & Therapy ·Maximilian Linxweiler, Silke Wemmert, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Luc G.T. Morris, (unknown)	1
5	FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling 2023 ·Scientific Reports ·(unknown), Martín Neumann, Patrícia M. A. Silva, Jutta Ortiz-Tánchez, (unknown), Konstandina Isaakidis, Cornelia Schlee, M. Schroeder, (unknown), Luc G.T. Morris, Timothy A. Chan, Lorenz Bastian, Thomas Burmeister, Stefan Schwartz, Nicola Gökbuget, Liliana H. Mochmann, Claudia D. Baldus	5
6	Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma 2023 ·Cancers ·Andrew S. Lee, Cristina Valero, Seong‐Keun Yoo, Joris L. Vos, Diego Chowell, Luc G.T. Morris	1
7	Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients 2022 ·The International Journal of Biological Markers ·(unknown), Florian Bochen, (unknown), Bernhard Schick, Mathias Wagner, Sigrun Smola, Barbara Berkó‐Göttel, Luc G.T. Morris, Jingming Wang, (unknown), Maximilian Linxweiler	2
8	Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma 2022 ·Cancers ·Joseph O. Humtsoe, Hyun‐Su Kim, (unknown), (unknown), (unknown), Fengshen Kuo, Luc G.T. Morris, Patrick K. Ha	11
9	HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction? 2021 ·Cancers ·(unknown), (unknown), (unknown), Florian Bochen, Silke Wemmert, (unknown), Sigrun Smola, Julia Caroline Radosa, Mathias Wagner, Luc G.T. Morris, Alessandro Bozzato, (unknown), Bernhard Schick, Maximilian Linxweiler	24
10	The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype 2020 ·Clinical Cancer Research ·Maximilian Linxweiler, Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin, Vladimir Makarov, Diego Chowell, Snjezana Doğan, Ian Ganly, A. Ari Hakimi, Richard J. Wong, Nadeem Riaz, Alan L. Ho, Timothy A. Chan, Luc G.T. Morris	79
11	Nodal disease burden and outcome of medullary thyroid carcinoma 2020 ·Head & Neck ·(unknown), Jamie R. Oliver, (unknown), (unknown), Kepal N. Patel, Luc G.T. Morris, Babak Givi	12
12	Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma 2019 ·Cancer ·Jamie R. Oliver, Seth Lieberman, Moses Tam, Liu C, Zujun Li, Kenneth S. Hu, Luc G.T. Morris, Babak Givi	53
13	Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma 2018 ·Journal of Surgical Oncology ·(unknown), Qasim Husain, Benjamin R. Roman, Jennifer R. Cracchiolo, Yao Yu, (unknown), Julie Kang, Sean M. McBride, Nancy Y. Lee, Luc G.T. Morris, Ian Ganly, Viviane Tabar, Marc A. Cohen	31
14	PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs 2017 ·Cancer Research ·Austin K. Mattox, Jina Lee, William H. Westra, Robert H. Pierce, Ronald Ghossein, William C. Faquin, Thomas Diefenbach, Luc G.T. Morris, Derrick T. Lin, Lori J. Wirth, (unknown), Eiichi Ishida, (unknown), (unknown), Yang Zeng, Huabiao Chen, Mark C. Poznansky, Neil M. Iyengar, Sara I. Pai	76
15	Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence 2017 ·Clinical Cancer Research ·Tihana Ibrahimpašić, Bin Xu, Iñigo Landa, Snjezana Doğan, Sumit Middha, Venkatraman Seshan, (unknown), Diane L. Carlson, Jocelyn Migliacci, Jeffrey A. Knauf, Brian R. Untch, Michael F. Berger, Luc G.T. Morris, R. Michael Tuttle, Timothy A. Chan, James A. Fagin, Ronald Ghossein, Ian Ganly	94
16	Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database 2017 ·Journal of Surgical Oncology ·Benjamin R. Roman, Shrujal S. Baxi, Jennifer R. Cracchiolo, (unknown), David G. Pfister, Sean M. McBride, Ian Ganly, Jatin P. Shah, Snehal G. Patel, Luc G.T. Morris, Marc A. Cohen	6
17	Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy breakdown → 2017 ·Science ·Diego Chowell, Luc G.T. Morris, Claud Grigg, Jeffrey K. Weber, Robert Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M. Kendall, David Requena, Nadeem Riaz, Benjamin D. Greenbaum, James M. Carroll, Edward B. Garon, David M. Hyman, Ahmet Zehir, David B. Solit, Michael F. Berger, Ruhong Zhou, Naiyer A. Rizvi, Timothy A. Chan	738
18	Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer 2016 ·Clinical Cancer Research ·Martin G. Dalin, Alexis Desrichard, Nora Katabi, Vladimir Makarov, Logan A. Walsh, Ken-Wing Lee, Qingguo Wang, Joshua Armenia, Lyndsay West, Snjezana Doğan, Lu Wang, Deepa Ramaswami, Alan L. Ho, Ian Ganly, David B. Solit, Michael F. Berger, Nikolaus Schultz, Jorge S. Reis‐Filho, Timothy A. Chan, Luc G.T. Morris	135
19	Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations 2015 ·Clinical Cancer Research ·Zachary S. Zumsteg, Natasha Morse, (unknown), Gaorav P. Gupta, Daniel S. Higginson, Nancy Y. Lee, Luc G.T. Morris, Ian Ganly, (unknown), Simon N. Powell, Christine H. Chung, Maurizio Scaltriti, José Baselga	68
20	Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer 2010 ·Journal of Clinical Oncology ·Luc G.T. Morris, Andrew G. Sikora, Snehal G. Patel, Richard B. Hayes, Ian Ganly	254

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact